First Zurich Immuno-Oncology Symposium

The advent of immunotherapy brings new opportunities, but also new challenges to physicians advising patients and treating patients. We invite you to take part in the First Zurich Immuno-Oncology Symposium of the Cancer Center Zürich to familiarize yourself with the new developments.
Datum
25.08.2016
Zeit
09.15-17.00 Uhr
Ort
UniversityHospital Zurich
Grosser Hörsaal Ost, HOER B 10
Adresse
Gloriastrasse 29
8091 Zurich

​​

Immunotherapy with immune checkpoint inhibitors has become a reality for patients with metastatic melanoma and patients with advanced non-small cell lung cancer with progressive disease after first line chemotherapy. Available data indicate patients with many other malignant diseases are likely to benefit from this form of therapy.
The advent of immunotherapy brings new opportunities, but also new challenges to physicians advising patients and treating patients. We invite you to take part in the First Zurich Immuno-Oncology Symposium of the Cancer Center Zürich to familiarize yourself with the new developments.

Program

Program First Zurich Immuno-Oncology Symposium (PDF)

Presentations

All presentations are available at Oncoletter.ch